Disc is also running a 26-subject open-label phase 2 study of bitopertin in patients with EPP and XLP, called BEACON, which was reported at last year's American Society of Haematology ...

Find the latest Orthopedics news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.